nodes	percent_of_prediction	percent_of_DWPC	metapath
Ruxolitinib—RPS6KA6—embryo—gestational diabetes	0.0148	0.0229	CbGeAlD
Ruxolitinib—PLK3—islet of Langerhans—gestational diabetes	0.0128	0.0197	CbGeAlD
Ruxolitinib—PLK3—embryo—gestational diabetes	0.0124	0.0191	CbGeAlD
Ruxolitinib—GRK7—head—gestational diabetes	0.0111	0.017	CbGeAlD
Ruxolitinib—PRKCE—adipose tissue—gestational diabetes	0.0102	0.0157	CbGeAlD
Ruxolitinib—ANKK1—head—gestational diabetes	0.0101	0.0156	CbGeAlD
Ruxolitinib—PLK1—uterus—gestational diabetes	0.01	0.0154	CbGeAlD
Ruxolitinib—JAK1—islet of Langerhans—gestational diabetes	0.00983	0.0151	CbGeAlD
Ruxolitinib—JAK1—embryo—gestational diabetes	0.00951	0.0146	CbGeAlD
Ruxolitinib—DCLK1—embryo—gestational diabetes	0.00951	0.0146	CbGeAlD
Ruxolitinib—STK16—islet of Langerhans—gestational diabetes	0.00923	0.0142	CbGeAlD
Ruxolitinib—DAPK3—islet of Langerhans—gestational diabetes	0.00882	0.0136	CbGeAlD
Ruxolitinib—PRKG2—head—gestational diabetes	0.00838	0.0129	CbGeAlD
Ruxolitinib—ROCK1—embryo—gestational diabetes	0.00819	0.0126	CbGeAlD
Ruxolitinib—PLK3—adipose tissue—gestational diabetes	0.00817	0.0126	CbGeAlD
Ruxolitinib—GRK1—head—gestational diabetes	0.008	0.0123	CbGeAlD
Ruxolitinib—NUAK2—islet of Langerhans—gestational diabetes	0.00786	0.0121	CbGeAlD
Ruxolitinib—PRKCE—head—gestational diabetes	0.00783	0.0121	CbGeAlD
Ruxolitinib—DCLK3—vagina—gestational diabetes	0.00772	0.0119	CbGeAlD
Ruxolitinib—CAMK1—adipose tissue—gestational diabetes	0.00764	0.0118	CbGeAlD
Ruxolitinib—PLK1—head—gestational diabetes	0.00752	0.0116	CbGeAlD
Ruxolitinib—RPS6KA6—head—gestational diabetes	0.00752	0.0116	CbGeAlD
Ruxolitinib—MAST1—head—gestational diabetes	0.00752	0.0116	CbGeAlD
Ruxolitinib—MARK2—adipose tissue—gestational diabetes	0.00742	0.0114	CbGeAlD
Ruxolitinib—DCLK3—head—gestational diabetes	0.00713	0.011	CbGeAlD
Ruxolitinib—TAOK2—adipose tissue—gestational diabetes	0.00687	0.0106	CbGeAlD
Ruxolitinib—PLK3—vagina—gestational diabetes	0.00679	0.0105	CbGeAlD
Ruxolitinib—TYK2—islet of Langerhans—gestational diabetes	0.0065	0.01	CbGeAlD
Ruxolitinib—MKNK2—islet of Langerhans—gestational diabetes	0.00642	0.00988	CbGeAlD
Ruxolitinib—IRAK1—islet of Langerhans—gestational diabetes	0.00642	0.00988	CbGeAlD
Ruxolitinib—JAK1—uterus—gestational diabetes	0.00641	0.00987	CbGeAlD
Ruxolitinib—DCLK1—uterus—gestational diabetes	0.00641	0.00987	CbGeAlD
Ruxolitinib—CAMK1—vagina—gestational diabetes	0.00635	0.00979	CbGeAlD
Ruxolitinib—JAK3—adipose tissue—gestational diabetes	0.00631	0.00972	CbGeAlD
Ruxolitinib—PLK3—head—gestational diabetes	0.00628	0.00966	CbGeAlD
Ruxolitinib—JAK1—adipose tissue—gestational diabetes	0.00627	0.00966	CbGeAlD
Ruxolitinib—DCLK1—adipose tissue—gestational diabetes	0.00627	0.00966	CbGeAlD
Ruxolitinib—CAMK1D—adipose tissue—gestational diabetes	0.00612	0.00942	CbGeAlD
Ruxolitinib—PHKG2—adipose tissue—gestational diabetes	0.00608	0.00937	CbGeAlD
Ruxolitinib—LTK—head—gestational diabetes	0.00606	0.00933	CbGeAlD
Ruxolitinib—RET—embryo—gestational diabetes	0.00605	0.00932	CbGeAlD
Ruxolitinib—DAPK2—adipose tissue—gestational diabetes	0.00598	0.00921	CbGeAlD
Ruxolitinib—STK16—adipose tissue—gestational diabetes	0.00588	0.00906	CbGeAlD
Ruxolitinib—CAMK1—head—gestational diabetes	0.00587	0.00904	CbGeAlD
Ruxolitinib—HIPK2—adipose tissue—gestational diabetes	0.00585	0.00901	CbGeAlD
Ruxolitinib—DAPK3—uterus—gestational diabetes	0.00575	0.00885	CbGeAlD
Ruxolitinib—JAK2—embryo—gestational diabetes	0.00572	0.00881	CbGeAlD
Ruxolitinib—TAOK2—vagina—gestational diabetes	0.00571	0.00879	CbGeAlD
Ruxolitinib—MARK2—head—gestational diabetes	0.0057	0.00878	CbGeAlD
Ruxolitinib—DAPK3—adipose tissue—gestational diabetes	0.00562	0.00866	CbGeAlD
Ruxolitinib—CLK2—adipose tissue—gestational diabetes	0.00557	0.00858	CbGeAlD
Ruxolitinib—BMPR2—uterus—gestational diabetes	0.00536	0.00826	CbGeAlD
Ruxolitinib—DYRK1A—adipose tissue—gestational diabetes	0.00527	0.00811	CbGeAlD
Ruxolitinib—BMPR2—adipose tissue—gestational diabetes	0.00525	0.00808	CbGeAlD
Ruxolitinib—JAK1—vagina—gestational diabetes	0.00521	0.00803	CbGeAlD
Ruxolitinib—DCLK1—vagina—gestational diabetes	0.00521	0.00803	CbGeAlD
Ruxolitinib—TAOK3—islet of Langerhans—gestational diabetes	0.0052	0.008	CbGeAlD
Ruxolitinib—CAMK1D—vagina—gestational diabetes	0.00509	0.00783	CbGeAlD
Ruxolitinib—NUAK2—adipose tissue—gestational diabetes	0.00501	0.00772	CbGeAlD
Ruxolitinib—DAPK2—vagina—gestational diabetes	0.00497	0.00766	CbGeAlD
Ruxolitinib—STK16—vagina—gestational diabetes	0.00489	0.00753	CbGeAlD
Ruxolitinib—JAK3—head—gestational diabetes	0.00485	0.00746	CbGeAlD
Ruxolitinib—JAK1—head—gestational diabetes	0.00481	0.00741	CbGeAlD
Ruxolitinib—DCLK1—head—gestational diabetes	0.00481	0.00741	CbGeAlD
Ruxolitinib—CAMK2G—uterus—gestational diabetes	0.0048	0.00739	CbGeAlD
Ruxolitinib—CAMK1D—head—gestational diabetes	0.0047	0.00724	CbGeAlD
Ruxolitinib—CAMK2G—adipose tissue—gestational diabetes	0.00469	0.00723	CbGeAlD
Ruxolitinib—BMP2K—adipose tissue—gestational diabetes	0.00469	0.00723	CbGeAlD
Ruxolitinib—DAPK3—vagina—gestational diabetes	0.00468	0.0072	CbGeAlD
Ruxolitinib—PHKG2—head—gestational diabetes	0.00467	0.00719	CbGeAlD
Ruxolitinib—LRRK2—adipose tissue—gestational diabetes	0.00465	0.00716	CbGeAlD
Ruxolitinib—CLK2—vagina—gestational diabetes	0.00463	0.00713	CbGeAlD
Ruxolitinib—STK16—head—gestational diabetes	0.00452	0.00696	CbGeAlD
Ruxolitinib—HIPK2—head—gestational diabetes	0.0045	0.00692	CbGeAlD
Ruxolitinib—MAP3K19—head—gestational diabetes	0.0044	0.00678	CbGeAlD
Ruxolitinib—BMPR2—vagina—gestational diabetes	0.00436	0.00671	CbGeAlD
Ruxolitinib—MAP3K2—uterus—gestational diabetes	0.00436	0.00671	CbGeAlD
Ruxolitinib—DAPK3—head—gestational diabetes	0.00432	0.00665	CbGeAlD
Ruxolitinib—MAP3K7—uterus—gestational diabetes	0.00432	0.00665	CbGeAlD
Ruxolitinib—CLK2—head—gestational diabetes	0.00428	0.00659	CbGeAlD
Ruxolitinib—MAP3K2—adipose tissue—gestational diabetes	0.00426	0.00656	CbGeAlD
Ruxolitinib—TYK2—uterus—gestational diabetes	0.00424	0.00653	CbGeAlD
Ruxolitinib—MAP3K7—adipose tissue—gestational diabetes	0.00422	0.0065	CbGeAlD
Ruxolitinib—MKNK2—uterus—gestational diabetes	0.00418	0.00644	CbGeAlD
Ruxolitinib—NUAK2—vagina—gestational diabetes	0.00417	0.00642	CbGeAlD
Ruxolitinib—ROCK1—head—gestational diabetes	0.00415	0.00638	CbGeAlD
Ruxolitinib—TYK2—adipose tissue—gestational diabetes	0.00415	0.00638	CbGeAlD
Ruxolitinib—MKNK2—adipose tissue—gestational diabetes	0.00409	0.0063	CbGeAlD
Ruxolitinib—IRAK1—adipose tissue—gestational diabetes	0.00409	0.0063	CbGeAlD
Ruxolitinib—DYRK1A—head—gestational diabetes	0.00404	0.00623	CbGeAlD
Ruxolitinib—BMPR2—head—gestational diabetes	0.00403	0.0062	CbGeAlD
Ruxolitinib—CAMK2G—vagina—gestational diabetes	0.0039	0.00601	CbGeAlD
Ruxolitinib—BMP2K—vagina—gestational diabetes	0.0039	0.00601	CbGeAlD
Ruxolitinib—LRRK2—vagina—gestational diabetes	0.00387	0.00595	CbGeAlD
Ruxolitinib—JAK2—adipose tissue—gestational diabetes	0.00377	0.00581	CbGeAlD
Ruxolitinib—MAP3K3—adipose tissue—gestational diabetes	0.00364	0.0056	CbGeAlD
Ruxolitinib—BMP2K—head—gestational diabetes	0.0036	0.00555	CbGeAlD
Ruxolitinib—CAMK2G—head—gestational diabetes	0.0036	0.00555	CbGeAlD
Ruxolitinib—LRRK2—head—gestational diabetes	0.00357	0.0055	CbGeAlD
Ruxolitinib—MAP3K7—vagina—gestational diabetes	0.00351	0.0054	CbGeAlD
Ruxolitinib—TYK2—vagina—gestational diabetes	0.00345	0.00531	CbGeAlD
Ruxolitinib—MKNK2—vagina—gestational diabetes	0.0034	0.00524	CbGeAlD
Ruxolitinib—TAOK3—uterus—gestational diabetes	0.00339	0.00522	CbGeAlD
Ruxolitinib—TAOK3—adipose tissue—gestational diabetes	0.00331	0.0051	CbGeAlD
Ruxolitinib—MAP3K2—head—gestational diabetes	0.00327	0.00504	CbGeAlD
Ruxolitinib—TYK2—head—gestational diabetes	0.00318	0.0049	CbGeAlD
Ruxolitinib—MKNK2—head—gestational diabetes	0.00314	0.00484	CbGeAlD
Ruxolitinib—JAK2—vagina—gestational diabetes	0.00314	0.00483	CbGeAlD
Ruxolitinib—RET—head—gestational diabetes	0.00306	0.00472	CbGeAlD
Ruxolitinib—MAP3K3—vagina—gestational diabetes	0.00302	0.00465	CbGeAlD
Ruxolitinib—JAK2—head—gestational diabetes	0.0029	0.00446	CbGeAlD
Ruxolitinib—MAP3K3—head—gestational diabetes	0.00279	0.0043	CbGeAlD
Ruxolitinib—TAOK3—vagina—gestational diabetes	0.00276	0.00424	CbGeAlD
Ruxolitinib—TAOK3—head—gestational diabetes	0.00255	0.00392	CbGeAlD
Ruxolitinib—GRK1—Disease—RBP4—gestational diabetes	0.000937	0.00267	CbGpPWpGaD
Ruxolitinib—JAK1—Signaling by Insulin receptor—FGF2—gestational diabetes	0.000928	0.00265	CbGpPWpGaD
Ruxolitinib—RPS6KA6—Developmental Biology—LEP—gestational diabetes	0.000927	0.00264	CbGpPWpGaD
Ruxolitinib—MAP3K7—FAS pathway and Stress induction of HSP regulation—TNF—gestational diabetes	0.000912	0.0026	CbGpPWpGaD
Ruxolitinib—MAP3K7—TWEAK Signaling Pathway—TNF—gestational diabetes	0.000912	0.0026	CbGpPWpGaD
Ruxolitinib—PRKCE—DAP12 interactions—FGF2—gestational diabetes	0.000912	0.0026	CbGpPWpGaD
Ruxolitinib—PRKCE—Signaling by FGFR in disease—FGF2—gestational diabetes	0.000912	0.0026	CbGpPWpGaD
Ruxolitinib—PRKG2—Signaling Pathways—LEPR—gestational diabetes	0.000906	0.00258	CbGpPWpGaD
Ruxolitinib—PRKCE—Signaling by EGFR—FGF2—gestational diabetes	0.000904	0.00258	CbGpPWpGaD
Ruxolitinib—PRKCE—Signaling by EGFR in Cancer—FGF2—gestational diabetes	0.000896	0.00255	CbGpPWpGaD
Ruxolitinib—PRKCE—Signaling by PDGF—FGF2—gestational diabetes	0.000892	0.00254	CbGpPWpGaD
Ruxolitinib—TYK2—IRS-mediated signalling—FGF2—gestational diabetes	0.000879	0.00251	CbGpPWpGaD
Ruxolitinib—TYK2—IRS-related events—FGF2—gestational diabetes	0.000855	0.00244	CbGpPWpGaD
Ruxolitinib—GRK1—Signaling Pathways—LEPR—gestational diabetes	0.000852	0.00243	CbGpPWpGaD
Ruxolitinib—MAP3K7—TNF receptor signaling pathway —TNF—gestational diabetes	0.000848	0.00242	CbGpPWpGaD
Ruxolitinib—PHKG2—Disease—RBP4—gestational diabetes	0.000847	0.00242	CbGpPWpGaD
Ruxolitinib—TYK2—IRS-related events triggered by IGF1R—FGF2—gestational diabetes	0.000847	0.00242	CbGpPWpGaD
Ruxolitinib—GRK1—Disease—NAMPT—gestational diabetes	0.00084	0.0024	CbGpPWpGaD
Ruxolitinib—MAP3K3—TNF alpha Signaling Pathway—TNF—gestational diabetes	0.000839	0.00239	CbGpPWpGaD
Ruxolitinib—GRK1—Disease—GCK—gestational diabetes	0.000835	0.00238	CbGpPWpGaD
Ruxolitinib—TYK2—IGF1R signaling cascade—FGF2—gestational diabetes	0.000825	0.00235	CbGpPWpGaD
Ruxolitinib—TYK2—Insulin receptor signalling cascade—FGF2—gestational diabetes	0.000825	0.00235	CbGpPWpGaD
Ruxolitinib—PRKCE—NGF signalling via TRKA from the plasma membrane—FGF2—gestational diabetes	0.000808	0.0023	CbGpPWpGaD
Ruxolitinib—JAK1—Signaling by SCF-KIT—FGF2—gestational diabetes	0.000794	0.00227	CbGpPWpGaD
Ruxolitinib—JAK2—IL23-mediated signaling events—TNF—gestational diabetes	0.000789	0.00225	CbGpPWpGaD
Ruxolitinib—RET—SIDS Susceptibility Pathways—TNF—gestational diabetes	0.000771	0.0022	CbGpPWpGaD
Ruxolitinib—BMPR2—Signaling Pathways—LEPR—gestational diabetes	0.00077	0.0022	CbGpPWpGaD
Ruxolitinib—PHKG2—Disease—NAMPT—gestational diabetes	0.00076	0.00217	CbGpPWpGaD
Ruxolitinib—JAK1—Downstream signaling of activated FGFR—FGF2—gestational diabetes	0.00076	0.00217	CbGpPWpGaD
Ruxolitinib—PHKG2—Disease—GCK—gestational diabetes	0.000755	0.00215	CbGpPWpGaD
Ruxolitinib—JAK1—Developmental Biology—GCK—gestational diabetes	0.00075	0.00214	CbGpPWpGaD
Ruxolitinib—PRKG2—Metabolism—NAMPT—gestational diabetes	0.000749	0.00214	CbGpPWpGaD
Ruxolitinib—JAK1—Signaling by ERBB4—FGF2—gestational diabetes	0.000748	0.00213	CbGpPWpGaD
Ruxolitinib—ROCK1—Regulation of Actin Cytoskeleton—FGF2—gestational diabetes	0.000747	0.00213	CbGpPWpGaD
Ruxolitinib—PRKG2—Metabolism—GCK—gestational diabetes	0.000744	0.00212	CbGpPWpGaD
Ruxolitinib—PLK1—Regulation of toll-like receptor signaling pathway—TNF—gestational diabetes	0.000739	0.00211	CbGpPWpGaD
Ruxolitinib—ROCK1—Developmental Biology—GCK—gestational diabetes	0.000737	0.0021	CbGpPWpGaD
Ruxolitinib—PRKCE—GPCR downstream signaling—MTNR1B—gestational diabetes	0.000737	0.0021	CbGpPWpGaD
Ruxolitinib—JAK1—Innate Immune System—MBL2—gestational diabetes	0.000737	0.0021	CbGpPWpGaD
Ruxolitinib—MAP3K7—Cardiac Hypertrophic Response—TNF—gestational diabetes	0.000735	0.0021	CbGpPWpGaD
Ruxolitinib—ROCK1—MicroRNAs in cardiomyocyte hypertrophy—TNF—gestational diabetes	0.00072	0.00205	CbGpPWpGaD
Ruxolitinib—PRKG2—Signaling Pathways—MTNR1B—gestational diabetes	0.000716	0.00204	CbGpPWpGaD
Ruxolitinib—JAK1—Downstream signal transduction—FGF2—gestational diabetes	0.000714	0.00204	CbGpPWpGaD
Ruxolitinib—JAK1—Signaling by FGFR—FGF2—gestational diabetes	0.000711	0.00203	CbGpPWpGaD
Ruxolitinib—JAK1—Signaling by ERBB2—FGF2—gestational diabetes	0.000707	0.00202	CbGpPWpGaD
Ruxolitinib—RPS6KA6—Developmental Biology—FGF2—gestational diabetes	0.000704	0.00201	CbGpPWpGaD
Ruxolitinib—JAK1—DAP12 signaling—FGF2—gestational diabetes	0.000704	0.00201	CbGpPWpGaD
Ruxolitinib—PRKG2—Signaling Pathways—RBP4—gestational diabetes	0.000698	0.00199	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling by Insulin receptor—FGF2—gestational diabetes	0.000685	0.00195	CbGpPWpGaD
Ruxolitinib—HIPK2—Gene Expression—AR—gestational diabetes	0.00068	0.00194	CbGpPWpGaD
Ruxolitinib—GRK1—Signaling Pathways—MTNR1B—gestational diabetes	0.000673	0.00192	CbGpPWpGaD
Ruxolitinib—PRKCE—Signaling by GPCR—MTNR1B—gestational diabetes	0.000669	0.00191	CbGpPWpGaD
Ruxolitinib—JAK2—IRS-mediated signalling—FGF2—gestational diabetes	0.000666	0.0019	CbGpPWpGaD
Ruxolitinib—JAK1—DAP12 interactions—FGF2—gestational diabetes	0.000662	0.00189	CbGpPWpGaD
Ruxolitinib—JAK1—Fc epsilon receptor (FCERI) signaling—FGF2—gestational diabetes	0.000662	0.00189	CbGpPWpGaD
Ruxolitinib—JAK1—Signaling by FGFR in disease—FGF2—gestational diabetes	0.000662	0.00189	CbGpPWpGaD
Ruxolitinib—JAK1—Signaling by EGFR—FGF2—gestational diabetes	0.000656	0.00187	CbGpPWpGaD
Ruxolitinib—GRK1—Signaling Pathways—RBP4—gestational diabetes	0.000656	0.00187	CbGpPWpGaD
Ruxolitinib—JAK1—Signaling by EGFR in Cancer—FGF2—gestational diabetes	0.00065	0.00185	CbGpPWpGaD
Ruxolitinib—JAK2—IRS-related events—FGF2—gestational diabetes	0.000648	0.00185	CbGpPWpGaD
Ruxolitinib—JAK1—Signaling by PDGF—FGF2—gestational diabetes	0.000647	0.00185	CbGpPWpGaD
Ruxolitinib—JAK2—IRS-related events triggered by IGF1R—FGF2—gestational diabetes	0.000642	0.00183	CbGpPWpGaD
Ruxolitinib—PHKG2—Metabolism—NAMPT—gestational diabetes	0.000636	0.00182	CbGpPWpGaD
Ruxolitinib—PHKG2—Metabolism—GCK—gestational diabetes	0.000632	0.0018	CbGpPWpGaD
Ruxolitinib—JAK2—IGF1R signaling cascade—FGF2—gestational diabetes	0.000625	0.00178	CbGpPWpGaD
Ruxolitinib—JAK2—Insulin receptor signalling cascade—FGF2—gestational diabetes	0.000625	0.00178	CbGpPWpGaD
Ruxolitinib—JAK3—GPCR downstream signaling—MTNR1B—gestational diabetes	0.000622	0.00177	CbGpPWpGaD
Ruxolitinib—PRKCE—Signaling by NGF—FGF2—gestational diabetes	0.000621	0.00177	CbGpPWpGaD
Ruxolitinib—JAK1—Developmental Biology—ADIPOQ—gestational diabetes	0.000617	0.00176	CbGpPWpGaD
Ruxolitinib—BMPR2—Signaling Pathways—MTNR1B—gestational diabetes	0.000609	0.00174	CbGpPWpGaD
Ruxolitinib—ROCK1—Developmental Biology—ADIPOQ—gestational diabetes	0.000607	0.00173	CbGpPWpGaD
Ruxolitinib—MAP3K2—MAPK Signaling Pathway—TNF—gestational diabetes	0.000602	0.00172	CbGpPWpGaD
Ruxolitinib—BMPR2—Signaling Pathways—RBP4—gestational diabetes	0.000593	0.00169	CbGpPWpGaD
Ruxolitinib—PRKCE—Immune System—MBL2—gestational diabetes	0.000591	0.00169	CbGpPWpGaD
Ruxolitinib—JAK1—NGF signalling via TRKA from the plasma membrane—FGF2—gestational diabetes	0.000586	0.00167	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling by SCF-KIT—FGF2—gestational diabetes	0.000586	0.00167	CbGpPWpGaD
Ruxolitinib—CYP3A4—Biological oxidations—GGCT—gestational diabetes	0.000579	0.00165	CbGpPWpGaD
Ruxolitinib—CYP3A4—Tryptophan metabolism—CYP19A1—gestational diabetes	0.000579	0.00165	CbGpPWpGaD
Ruxolitinib—PLK1—Integrated Pancreatic Cancer Pathway—TNF—gestational diabetes	0.000573	0.00164	CbGpPWpGaD
Ruxolitinib—JAK3—Signaling by GPCR—MTNR1B—gestational diabetes	0.000565	0.00161	CbGpPWpGaD
Ruxolitinib—TYK2—Downstream signaling of activated FGFR—FGF2—gestational diabetes	0.000561	0.0016	CbGpPWpGaD
Ruxolitinib—IRAK1—Innate Immune System—MBL2—gestational diabetes	0.00056	0.0016	CbGpPWpGaD
Ruxolitinib—TYK2—Developmental Biology—GCK—gestational diabetes	0.000553	0.00158	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling by ERBB4—FGF2—gestational diabetes	0.000552	0.00157	CbGpPWpGaD
Ruxolitinib—PRKCE—Disease—RBP4—gestational diabetes	0.00055	0.00157	CbGpPWpGaD
Ruxolitinib—PRKG2—Metabolism—CYP19A1—gestational diabetes	0.000544	0.00155	CbGpPWpGaD
Ruxolitinib—TYK2—Innate Immune System—MBL2—gestational diabetes	0.000544	0.00155	CbGpPWpGaD
Ruxolitinib—CAMK2G—Immune System—MBL2—gestational diabetes	0.000541	0.00154	CbGpPWpGaD
Ruxolitinib—JAK1—GPCR downstream signaling—MTNR1B—gestational diabetes	0.000535	0.00153	CbGpPWpGaD
Ruxolitinib—MAP3K3—Immune System—MBL2—gestational diabetes	0.000529	0.00151	CbGpPWpGaD
Ruxolitinib—MAP3K7—Innate Immune System—MBL2—gestational diabetes	0.000527	0.0015	CbGpPWpGaD
Ruxolitinib—TYK2—Downstream signal transduction—FGF2—gestational diabetes	0.000527	0.0015	CbGpPWpGaD
Ruxolitinib—ROCK1—GPCR downstream signaling—MTNR1B—gestational diabetes	0.000526	0.0015	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling by FGFR—FGF2—gestational diabetes	0.000525	0.0015	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling by ERBB2—FGF2—gestational diabetes	0.000522	0.00149	CbGpPWpGaD
Ruxolitinib—TYK2—DAP12 signaling—FGF2—gestational diabetes	0.000519	0.00148	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling by Insulin receptor—FGF2—gestational diabetes	0.000519	0.00148	CbGpPWpGaD
Ruxolitinib—PRKCE—Signaling Pathways—LEPR—gestational diabetes	0.0005	0.00143	CbGpPWpGaD
Ruxolitinib—JAK3—Immune System—MBL2—gestational diabetes	0.000499	0.00142	CbGpPWpGaD
Ruxolitinib—MAP3K7—Downstream signaling events of B Cell Receptor (BCR)—FGF2—gestational diabetes	0.000497	0.00142	CbGpPWpGaD
Ruxolitinib—PRKCE—Disease—NAMPT—gestational diabetes	0.000493	0.00141	CbGpPWpGaD
Ruxolitinib—PRKCE—Disease—GCK—gestational diabetes	0.00049	0.0014	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling by FGFR in disease—FGF2—gestational diabetes	0.000489	0.00139	CbGpPWpGaD
Ruxolitinib—TYK2—DAP12 interactions—FGF2—gestational diabetes	0.000489	0.00139	CbGpPWpGaD
Ruxolitinib—TYK2—Fc epsilon receptor (FCERI) signaling—FGF2—gestational diabetes	0.000489	0.00139	CbGpPWpGaD
Ruxolitinib—MAP3K7—TNF alpha Signaling Pathway—TNF—gestational diabetes	0.000487	0.00139	CbGpPWpGaD
Ruxolitinib—JAK1—Signaling by GPCR—MTNR1B—gestational diabetes	0.000486	0.00139	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling by EGFR—FGF2—gestational diabetes	0.000484	0.00138	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling by EGFR in Cancer—FGF2—gestational diabetes	0.00048	0.00137	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling by PDGF—FGF2—gestational diabetes	0.000478	0.00136	CbGpPWpGaD
Ruxolitinib—ROCK1—Signaling by GPCR—MTNR1B—gestational diabetes	0.000478	0.00136	CbGpPWpGaD
Ruxolitinib—IRAK1—Toll-like Receptor Signaling Pathway—TNF—gestational diabetes	0.000476	0.00136	CbGpPWpGaD
Ruxolitinib—MAP3K7—Fc epsilon receptor (FCERI) signaling—FGF2—gestational diabetes	0.000474	0.00135	CbGpPWpGaD
Ruxolitinib—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP19A1—gestational diabetes	0.000468	0.00134	CbGpPWpGaD
Ruxolitinib—PHKG2—Metabolism—CYP19A1—gestational diabetes	0.000462	0.00132	CbGpPWpGaD
Ruxolitinib—CYP3A4—Oxidation by Cytochrome P450—CYP19A1—gestational diabetes	0.000462	0.00132	CbGpPWpGaD
Ruxolitinib—TYK2—Developmental Biology—ADIPOQ—gestational diabetes	0.000456	0.0013	CbGpPWpGaD
Ruxolitinib—JAK1—Signaling by NGF—FGF2—gestational diabetes	0.000451	0.00129	CbGpPWpGaD
Ruxolitinib—MAP3K7—Toll-like Receptor Signaling Pathway—TNF—gestational diabetes	0.000449	0.00128	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling by SCF-KIT—FGF2—gestational diabetes	0.000444	0.00127	CbGpPWpGaD
Ruxolitinib—ROCK1—Apoptosis—TNF—gestational diabetes	0.000441	0.00126	CbGpPWpGaD
Ruxolitinib—MAP3K7—B Cell Activation—FGF2—gestational diabetes	0.000439	0.00125	CbGpPWpGaD
Ruxolitinib—TYK2—NGF signalling via TRKA from the plasma membrane—FGF2—gestational diabetes	0.000433	0.00123	CbGpPWpGaD
Ruxolitinib—JAK1—Immune System—MBL2—gestational diabetes	0.000429	0.00122	CbGpPWpGaD
Ruxolitinib—RPS6KA6—Developmental Biology—TNF—gestational diabetes	0.000429	0.00122	CbGpPWpGaD
Ruxolitinib—JAK2—Downstream signaling of activated FGFR—FGF2—gestational diabetes	0.000425	0.00121	CbGpPWpGaD
Ruxolitinib—JAK3—Signaling Pathways—LEPR—gestational diabetes	0.000422	0.0012	CbGpPWpGaD
Ruxolitinib—JAK2—Developmental Biology—GCK—gestational diabetes	0.000419	0.0012	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling by ERBB4—FGF2—gestational diabetes	0.000418	0.00119	CbGpPWpGaD
Ruxolitinib—JAK2—Innate Immune System—MBL2—gestational diabetes	0.000412	0.00118	CbGpPWpGaD
Ruxolitinib—JAK2—Downstream signal transduction—FGF2—gestational diabetes	0.0004	0.00114	CbGpPWpGaD
Ruxolitinib—JAK1—Disease—RBP4—gestational diabetes	0.000399	0.00114	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling by FGFR—FGF2—gestational diabetes	0.000398	0.00113	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling by ERBB2—FGF2—gestational diabetes	0.000396	0.00113	CbGpPWpGaD
Ruxolitinib—PRKCE—Signaling Pathways—MTNR1B—gestational diabetes	0.000395	0.00113	CbGpPWpGaD
Ruxolitinib—JAK2—DAP12 signaling—FGF2—gestational diabetes	0.000394	0.00112	CbGpPWpGaD
Ruxolitinib—PRKCE—Signaling Pathways—RBP4—gestational diabetes	0.000385	0.0011	CbGpPWpGaD
Ruxolitinib—JAK1—Developmental Biology—LEP—gestational diabetes	0.000383	0.00109	CbGpPWpGaD
Ruxolitinib—CYP3A4—Phase 1 - Functionalization of compounds—CYP19A1—gestational diabetes	0.000379	0.00108	CbGpPWpGaD
Ruxolitinib—ROCK1—Developmental Biology—LEP—gestational diabetes	0.000377	0.00108	CbGpPWpGaD
Ruxolitinib—IRAK1—Regulation of toll-like receptor signaling pathway—TNF—gestational diabetes	0.000372	0.00106	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling by FGFR in disease—FGF2—gestational diabetes	0.00037	0.00106	CbGpPWpGaD
Ruxolitinib—JAK2—DAP12 interactions—FGF2—gestational diabetes	0.00037	0.00106	CbGpPWpGaD
Ruxolitinib—JAK2—Fc epsilon receptor (FCERI) signaling—FGF2—gestational diabetes	0.00037	0.00106	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling by EGFR—FGF2—gestational diabetes	0.000367	0.00105	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling by EGFR in Cancer—FGF2—gestational diabetes	0.000364	0.00104	CbGpPWpGaD
Ruxolitinib—JAK1—Signaling Pathways—LEPR—gestational diabetes	0.000363	0.00104	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling by PDGF—FGF2—gestational diabetes	0.000362	0.00103	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling by GPCR—MTNR1B—gestational diabetes	0.000359	0.00102	CbGpPWpGaD
Ruxolitinib—JAK1—Disease—NAMPT—gestational diabetes	0.000358	0.00102	CbGpPWpGaD
Ruxolitinib—ROCK1—Signaling Pathways—LEPR—gestational diabetes	0.000357	0.00102	CbGpPWpGaD
Ruxolitinib—JAK1—Disease—GCK—gestational diabetes	0.000356	0.00102	CbGpPWpGaD
Ruxolitinib—PRKCE—Innate Immune System—FGF2—gestational diabetes	0.000354	0.00101	CbGpPWpGaD
Ruxolitinib—MAP3K7—Regulation of toll-like receptor signaling pathway—TNF—gestational diabetes	0.00035	0.000999	CbGpPWpGaD
Ruxolitinib—JAK2—Developmental Biology—ADIPOQ—gestational diabetes	0.000345	0.000985	CbGpPWpGaD
Ruxolitinib—IRAK1—Signaling by NGF—FGF2—gestational diabetes	0.000343	0.000978	CbGpPWpGaD
Ruxolitinib—JAK3—Signaling Pathways—MTNR1B—gestational diabetes	0.000334	0.000952	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling by NGF—FGF2—gestational diabetes	0.000333	0.00095	CbGpPWpGaD
Ruxolitinib—JAK2—NGF signalling via TRKA from the plasma membrane—FGF2—gestational diabetes	0.000328	0.000936	CbGpPWpGaD
Ruxolitinib—IRAK1—Immune System—MBL2—gestational diabetes	0.000326	0.000931	CbGpPWpGaD
Ruxolitinib—JAK3—Signaling Pathways—RBP4—gestational diabetes	0.000325	0.000927	CbGpPWpGaD
Ruxolitinib—GRK1—Disease—FGF2—gestational diabetes	0.000324	0.000926	CbGpPWpGaD
Ruxolitinib—PRKG2—Signaling Pathways—LEP—gestational diabetes	0.000318	0.000907	CbGpPWpGaD
Ruxolitinib—TYK2—Immune System—MBL2—gestational diabetes	0.000317	0.000903	CbGpPWpGaD
Ruxolitinib—MAP3K7—Immune System—MBL2—gestational diabetes	0.000307	0.000876	CbGpPWpGaD
Ruxolitinib—MAP3K7—MAPK Signaling Pathway—TNF—gestational diabetes	0.000301	0.000858	CbGpPWpGaD
Ruxolitinib—JAK2—GPCR downstream signaling—MTNR1B—gestational diabetes	0.000299	0.000854	CbGpPWpGaD
Ruxolitinib—GRK1—Signaling Pathways—LEP—gestational diabetes	0.000299	0.000853	CbGpPWpGaD
Ruxolitinib—TYK2—Disease—RBP4—gestational diabetes	0.000295	0.000841	CbGpPWpGaD
Ruxolitinib—PHKG2—Disease—FGF2—gestational diabetes	0.000293	0.000837	CbGpPWpGaD
Ruxolitinib—JAK1—Developmental Biology—FGF2—gestational diabetes	0.000291	0.000831	CbGpPWpGaD
Ruxolitinib—JAK1—Signaling Pathways—MTNR1B—gestational diabetes	0.000287	0.000819	CbGpPWpGaD
Ruxolitinib—ROCK1—Developmental Biology—FGF2—gestational diabetes	0.000286	0.000817	CbGpPWpGaD
Ruxolitinib—TYK2—Developmental Biology—LEP—gestational diabetes	0.000283	0.000807	CbGpPWpGaD
Ruxolitinib—ROCK1—Signaling Pathways—MTNR1B—gestational diabetes	0.000282	0.000805	CbGpPWpGaD
Ruxolitinib—JAK1—Signaling Pathways—RBP4—gestational diabetes	0.00028	0.000798	CbGpPWpGaD
Ruxolitinib—IRAK1—Signaling Pathways—LEPR—gestational diabetes	0.000276	0.000787	CbGpPWpGaD
Ruxolitinib—ROCK1—Signaling Pathways—RBP4—gestational diabetes	0.000275	0.000785	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling by GPCR—MTNR1B—gestational diabetes	0.000272	0.000775	CbGpPWpGaD
Ruxolitinib—BMPR2—Signaling Pathways—LEP—gestational diabetes	0.000271	0.000772	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling Pathways—LEPR—gestational diabetes	0.000268	0.000764	CbGpPWpGaD
Ruxolitinib—TYK2—Disease—NAMPT—gestational diabetes	0.000264	0.000754	CbGpPWpGaD
Ruxolitinib—TYK2—Disease—GCK—gestational diabetes	0.000263	0.00075	CbGpPWpGaD
Ruxolitinib—MAP3K7—Signaling Pathways—LEPR—gestational diabetes	0.00026	0.000741	CbGpPWpGaD
Ruxolitinib—JAK1—Innate Immune System—FGF2—gestational diabetes	0.000257	0.000734	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling by NGF—FGF2—gestational diabetes	0.000252	0.00072	CbGpPWpGaD
Ruxolitinib—PRKG2—Signaling Pathways—FGF2—gestational diabetes	0.000242	0.000689	CbGpPWpGaD
Ruxolitinib—JAK2—Immune System—MBL2—gestational diabetes	0.00024	0.000685	CbGpPWpGaD
Ruxolitinib—GRK1—Signaling Pathways—FGF2—gestational diabetes	0.000227	0.000648	CbGpPWpGaD
Ruxolitinib—JAK2—Disease—RBP4—gestational diabetes	0.000223	0.000637	CbGpPWpGaD
Ruxolitinib—IRAK1—Signaling Pathways—MTNR1B—gestational diabetes	0.000218	0.000623	CbGpPWpGaD
Ruxolitinib—TYK2—Developmental Biology—FGF2—gestational diabetes	0.000215	0.000613	CbGpPWpGaD
Ruxolitinib—JAK2—Developmental Biology—LEP—gestational diabetes	0.000215	0.000612	CbGpPWpGaD
Ruxolitinib—IRAK1—Signaling Pathways—RBP4—gestational diabetes	0.000213	0.000607	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling Pathways—MTNR1B—gestational diabetes	0.000212	0.000604	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling Pathways—RBP4—gestational diabetes	0.000206	0.000589	CbGpPWpGaD
Ruxolitinib—PRKCE—Immune System—FGF2—gestational diabetes	0.000206	0.000589	CbGpPWpGaD
Ruxolitinib—BMPR2—Signaling Pathways—FGF2—gestational diabetes	0.000205	0.000586	CbGpPWpGaD
Ruxolitinib—MAP3K7—Signaling Pathways—MTNR1B—gestational diabetes	0.000205	0.000586	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—LEPR—gestational diabetes	0.000203	0.000579	CbGpPWpGaD
Ruxolitinib—CYP3A4—Biological oxidations—CYP19A1—gestational diabetes	0.000202	0.000575	CbGpPWpGaD
Ruxolitinib—JAK2—Disease—NAMPT—gestational diabetes	0.0002	0.000572	CbGpPWpGaD
Ruxolitinib—MAP3K7—Signaling Pathways—RBP4—gestational diabetes	0.0002	0.000571	CbGpPWpGaD
Ruxolitinib—JAK2—Disease—GCK—gestational diabetes	0.000199	0.000568	CbGpPWpGaD
Ruxolitinib—CYP3A4—Metapathway biotransformation—CYP19A1—gestational diabetes	0.000199	0.000567	CbGpPWpGaD
Ruxolitinib—IRAK1—Innate Immune System—FGF2—gestational diabetes	0.000196	0.000558	CbGpPWpGaD
Ruxolitinib—PRKCE—Disease—FGF2—gestational diabetes	0.000191	0.000543	CbGpPWpGaD
Ruxolitinib—TYK2—Innate Immune System—FGF2—gestational diabetes	0.00019	0.000542	CbGpPWpGaD
Ruxolitinib—CAMK2G—Immune System—FGF2—gestational diabetes	0.000189	0.000539	CbGpPWpGaD
Ruxolitinib—MAP3K3—Immune System—FGF2—gestational diabetes	0.000185	0.000527	CbGpPWpGaD
Ruxolitinib—MAP3K7—Innate Immune System—FGF2—gestational diabetes	0.000184	0.000525	CbGpPWpGaD
Ruxolitinib—JAK1—Developmental Biology—TNF—gestational diabetes	0.000177	0.000506	CbGpPWpGaD
Ruxolitinib—MAP3K7—Adaptive Immune System—FGF2—gestational diabetes	0.000177	0.000504	CbGpPWpGaD
Ruxolitinib—PRKCE—Signaling Pathways—LEP—gestational diabetes	0.000176	0.000501	CbGpPWpGaD
Ruxolitinib—ROCK1—Developmental Biology—TNF—gestational diabetes	0.000174	0.000498	CbGpPWpGaD
Ruxolitinib—JAK3—Immune System—FGF2—gestational diabetes	0.000174	0.000497	CbGpPWpGaD
Ruxolitinib—JAK2—Developmental Biology—FGF2—gestational diabetes	0.000163	0.000465	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—MTNR1B—gestational diabetes	0.000161	0.000458	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—RBP4—gestational diabetes	0.000156	0.000446	CbGpPWpGaD
Ruxolitinib—JAK1—Immune System—FGF2—gestational diabetes	0.00015	0.000427	CbGpPWpGaD
Ruxolitinib—JAK3—Signaling Pathways—LEP—gestational diabetes	0.000148	0.000423	CbGpPWpGaD
Ruxolitinib—JAK2—Innate Immune System—FGF2—gestational diabetes	0.000144	0.00041	CbGpPWpGaD
Ruxolitinib—JAK1—Disease—FGF2—gestational diabetes	0.000138	0.000395	CbGpPWpGaD
Ruxolitinib—PRKCE—Signaling Pathways—FGF2—gestational diabetes	0.000133	0.000381	CbGpPWpGaD
Ruxolitinib—TYK2—Developmental Biology—TNF—gestational diabetes	0.000131	0.000373	CbGpPWpGaD
Ruxolitinib—JAK1—Signaling Pathways—LEP—gestational diabetes	0.000128	0.000364	CbGpPWpGaD
Ruxolitinib—ROCK1—Signaling Pathways—LEP—gestational diabetes	0.000125	0.000358	CbGpPWpGaD
Ruxolitinib—IRAK1—Immune System—FGF2—gestational diabetes	0.000114	0.000325	CbGpPWpGaD
Ruxolitinib—JAK3—Signaling Pathways—FGF2—gestational diabetes	0.000113	0.000321	CbGpPWpGaD
Ruxolitinib—TYK2—Immune System—FGF2—gestational diabetes	0.000111	0.000315	CbGpPWpGaD
Ruxolitinib—MAP3K7—Immune System—FGF2—gestational diabetes	0.000107	0.000306	CbGpPWpGaD
Ruxolitinib—TYK2—Disease—FGF2—gestational diabetes	0.000102	0.000291	CbGpPWpGaD
Ruxolitinib—JAK2—Developmental Biology—TNF—gestational diabetes	9.92e-05	0.000283	CbGpPWpGaD
Ruxolitinib—CYP3A4—Metabolism—GGCT—gestational diabetes	9.91e-05	0.000283	CbGpPWpGaD
Ruxolitinib—IRAK1—Signaling Pathways—LEP—gestational diabetes	9.7e-05	0.000277	CbGpPWpGaD
Ruxolitinib—JAK1—Signaling Pathways—FGF2—gestational diabetes	9.69e-05	0.000276	CbGpPWpGaD
Ruxolitinib—ROCK1—Signaling Pathways—FGF2—gestational diabetes	9.53e-05	0.000272	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling Pathways—LEP—gestational diabetes	9.41e-05	0.000268	CbGpPWpGaD
Ruxolitinib—MAP3K7—Signaling Pathways—LEP—gestational diabetes	9.13e-05	0.00026	CbGpPWpGaD
Ruxolitinib—CYP3A4—Metabolism—GLS2—gestational diabetes	8.66e-05	0.000247	CbGpPWpGaD
Ruxolitinib—JAK2—Immune System—FGF2—gestational diabetes	8.38e-05	0.000239	CbGpPWpGaD
Ruxolitinib—JAK2—Disease—FGF2—gestational diabetes	7.74e-05	0.000221	CbGpPWpGaD
Ruxolitinib—IRAK1—Signaling Pathways—FGF2—gestational diabetes	7.37e-05	0.00021	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling Pathways—FGF2—gestational diabetes	7.15e-05	0.000204	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—LEP—gestational diabetes	7.13e-05	0.000203	CbGpPWpGaD
Ruxolitinib—MAP3K7—Signaling Pathways—FGF2—gestational diabetes	6.94e-05	0.000198	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—FGF2—gestational diabetes	5.42e-05	0.000155	CbGpPWpGaD
Ruxolitinib—CYP3A4—Metabolism—NAMPT—gestational diabetes	4.74e-05	0.000135	CbGpPWpGaD
Ruxolitinib—CYP3A4—Metabolism—GCK—gestational diabetes	4.71e-05	0.000134	CbGpPWpGaD
Ruxolitinib—CYP3A4—Metabolism—CYP19A1—gestational diabetes	3.45e-05	9.83e-05	CbGpPWpGaD
